Mouse models of Kaposi sarcoma-associated herpesvirus (KSHV)
- PMID: 39837218
- PMCID: PMC11788063
- DOI: 10.1016/j.virol.2024.110384
Mouse models of Kaposi sarcoma-associated herpesvirus (KSHV)
Abstract
Infection with Kaposi sarcoma-associated herpesvirus (KSHV) is a prerequisite for the development of several human cancers, including Kaposi sarcoma and primary effusion lymphoma. Efficient long-term infection with KSHV and subsequent virally induced cell transformation is limited to humans, resulting in a lack of small animal models for KSHV-driven malignancies. Various attempts to create a mouse model for KSHV include infection of humanized mice, generating transgenic mice that ectopically express viral proteins, and grafting KSHV-infected tumor, primary, or immortalized cells onto immunodeficient mice. While no single mouse model can recapitulate the full range of KSHV-associated pathologies described in humans, each model adds an essential piece to the complete picture of KSHV infection and oncogenesis.
Keywords: Cancer; GEMM; Herpesvirus; KSHV; Kaposi sarcoma; Mouse models.
Copyright © 2025 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Kaposi sarcoma-associated herpesvirus complement control protein (KCP) and glycoprotein K8.1 are not required for viral infection in vitro or in vivo.J Virol. 2024 Jun 13;98(6):e0057624. doi: 10.1128/jvi.00576-24. Epub 2024 May 20. J Virol. 2024. PMID: 38767375 Free PMC article.
-
The role of Kaposi sarcoma-associated herpesvirus in the pathogenesis of Kaposi sarcoma.J Pathol. 2015 Jan;235(2):368-80. doi: 10.1002/path.4441. J Pathol. 2015. PMID: 25212381 Review.
-
Development of KSHV vaccine platforms and chimeric MHV68-K-K8.1 glycoprotein for evaluating the in vivo immunogenicity and efficacy of KSHV vaccine candidates.mBio. 2024 Dec 11;15(12):e0291324. doi: 10.1128/mbio.02913-24. Epub 2024 Oct 30. mBio. 2024. PMID: 39475238 Free PMC article.
-
Update on Kaposi sarcoma-associated herpesvirus (KSHV or HHV8) - review.Rom J Intern Med. 2020 Dec 17;58(4):199-208. doi: 10.2478/rjim-2020-0017. Print 2020 Dec 1. Rom J Intern Med. 2020. PMID: 32681788 Review.
-
Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression.Cell Host Microbe. 2017 Jul 12;22(1):61-73.e7. doi: 10.1016/j.chom.2017.06.009. Cell Host Microbe. 2017. PMID: 28704654
References
-
- Aluigi MG, Albini A, Carlone S, Repetto L, De Marchi R, Icardi A, et al. KSHV sequences in biopsies and cultured spindle cells of epidemic, iatrogenic and Mediterranean forms of Kaposi’s sarcoma. Res Virol. 1996;147(5):267–75. - PubMed
-
- Ballestas ME, Chatis PA, Kaye KM. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science. 1999;284(5414):641–4. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical